High demand for new RSV treatment for infants outpaces national supply

Respiratory syncytial virus leads to as many as 80,000 hospitalizations and 300 deaths per year among children under 5, and is the leading cause of hospitalization for infants under 1 year old. Dr. Céline Gounder, an epidemiologist and senior fellow at KFF, joins Amna Nawaz to discuss the impact of a shortage of drugs to treat RSV.

Stream your PBS favorites with the PBS app: https://to.pbs.org/2Jb8twG
Find more from PBS NewsHour at https://www.pbs.org/newshour
Subscribe to our YouTube channel: https://bit.ly/2HfsCD6

Follow us:
TikTok: https://www.tiktok.com/@pbsnews
Twitter: http://www.twitter.com/newshour
Instagram: http://www.instagram.com/newshour
Facebook: http://www.pbs.org/newshour

Subscribe:
PBS NewsHour podcasts: https://www.pbs.org/newshour/podcasts
Newsletters: https://www.pbs.org/newshour/subscribe

Видео High demand for new RSV treatment for infants outpaces national supply канала PBS NewsHour